Guidance for Ultragenyx Pharmaceutical Inc. (RARE)
Period | Range | Estimate | Revenue Range | Revenue Estimate | Target | Details |
---|---|---|---|---|---|---|
2021 | N/A | N/A | $180.00M – 190.00M | N/A | = Maintained | Details |
2020 | N/A | N/A | $125.00M – 140.00M | $176.86M | = Maintained | Details |
Q3 2018 | N/A | N/A | N/A | N/A | = Maintained | Details |
Q2 2018 | N/A | N/A | N/A | N/A | = Maintained | Details |
Q1 2018 | N/A | N/A | N/A | N/A | = Maintained | Details |
Q4 2017 | N/A | N/A | N/A | N/A | = Maintained | Details |
Q3 2017 | N/A | N/A | N/A | N/A | = Maintained | Details |
Q2 2017 | N/A | N/A | N/A | N/A | = Maintained | Details |
Q1 2017 | N/A | N/A | N/A | N/A | = Maintained | Details |